extract: 2025-05-01-nejm-semaglutide-mash-phase3-liver
- Factual accuracy — The claims appear factually correct, describing the addition of liver protection as a third organ-protection pathway for GLP-1s and detailing the results of a Phase 3…
extract: 2025-03-17-norc-pace-market-assessment-for-profit-expansion
- Factual accuracy — The claims are factually correct, supported by the provided evidence from the NORC 2025 report.
- Intra-PR duplicates — There are no intra-PR duplicates; the new…
extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd
- Factual accuracy — The added evidence in both claims appears factually correct and is attributed to a source.
- Intra-PR duplicates — There are no intra-PR duplicates; the new…
extract: 2025-01-01-sage-algorithmic-content-creation-systematic-review
Approved (post-rebase re-approval).
extract: 2025-00-00-nhs-england-waiting-times-underfunding
- Factual accuracy — The claims are factually correct, supported by the provided evidence regarding NHS performance and Commonwealth Fund rankings.
- Intra-PR duplicates — There are…
extract: 2024-08-27-futardio-proposal-fund-the-drift-superteam-earn-creator-competition
Approved (post-rebase re-approval).
extract: 2024-08-14-futardio-proposal-develop-memecoin-launchpad
Approved (post-rebase re-approval).
extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes
- Factual accuracy — The claims are factually correct, supported by the new evidence from the NEJM FLOW trial.
- Intra-PR duplicates — There are no intra-PR duplicates; each claim…
extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift
- Factual accuracy — The claims are factually correct, supported by the provided evidence from the McKinsey source.
- Intra-PR duplicates — There are no intra-PR duplicates; the…